B
BioVertex Labs
Series A Raising
Developing next-generation therapeutics for chronic diseases.
Boston, USA Founded 2020 Employees 80+ biovertex.com
RAISING NOW
$18.7M / $25.0M
75%
Valuation
$150M
Min. Investment
$50K
Est. IPO
Q2 2026
Investors
143
Company Overview
BioVertex Labs is building category-defining technology in biotechnology. Developing next-generation therapeutics for chronic diseases.
$18.7M
Raised to Date
80%
Gross Margin
600+
Customers
3.2x
Revenue Growth
Investment Highlights
- Strong product-market fit with enterprise customers
- Rapid revenue growth and high gross margins
- Experienced leadership team with proven track record
- Large market opportunity in AI workflow automation
- Strategic partnerships with industry leaders
Traction & Growth
Revenue (USD) Net Revenue Retention (%)
Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025
$18.7M
Capital Raised
↑ Round in progress
$150M
Valuation Cap
80%
Gross Margin
120%
Net Revenue Retention
Offer Details
RoundSeries A
Total Raise$25.0M
Amount Raised$18.7M
Valuation Cap$150M
Min. Investment$50K
Investment TypeEquity
Est. IPOQ2 2026
Lock-up Period12 Months
Voting RightsPro Rata
Closing DateOpen
Accredited investors only
Use of Funds
40%Product Development$20.0M
25%Sales & Marketing$12.5M
20%Team Expansion$10.0M
10%Infrastructure$5.0M
5%Other / Working Capital$2.5M
Company Stage
Seed Round
Mar 2021Series A
Jun 2022Series B (Current)
May 2025Pre-IPO
Q1 2026IPO (Planned)
Q1 2026Lead Investors
A
Alpha VenturesLead InvestorN
NextGen CapitalPortfolio InvestorS
ScaleEdge PartnersStrategic InvestorAI
AI FundPortfolio InvestorTeam
Documents
View All DocumentsRecent Updates
May 12, 2025
Milestone
NovaTech Hits $18.7M ARR, Up 142% YoY
Strong enterprise demand continues to drive record growth.
Apr 28, 2025
Partnership
Partnership with Microsoft Azure
Integration will bring advanced AI capabilities to enterprise workflows.
Apr 10, 2025
Product
Launch of AI Workflow Builder
New product module enables no-code automation with AI assistance.
Invest in Innovation Before the World Does
Join thousands of investors accessing tomorrow’s leading companies today.
Curated Opportunities
Rigorous due diligence on every company.
Secure Platform
Institutional-grade security and compliance.
Expert Support
Dedicated team for your investment journey.